How Spravato Compares to Other Depression Treatments
Spravato stands apart from other treatments in several key ways. Compared to traditional antidepressants, it works much faster — in hours or days, not weeks — and uses a completely different mechanism in the brain, making it effective when others have failed. Unlike IV ketamine, Spravato is FDA-approved specifically for depression, which means it’s covered by insurance and follows standardized, federally mandated safety protocols. And when compared to a non-medication treatment like TMS, Spravato often provides a much quicker response, though the two can be powerfully combined for even better results.
Success Stories: Real Patients, Real Results
Getting Started with Spravato Treatment
Beginning your Spravato treatment is a thoughtful and supportive process designed to ensure your safety, maximize effectiveness, and secure insurance coverage from the very start. Your journey begins with a comprehensive evaluation where we’ll discuss your depression history, current symptoms, and carefully document the past treatments you’ve tried. This detailed review, along with a standard medical clearance, is essential for confirming that Spravato is a safe and appropriate choice for you and is a key step in gaining insurance approval.
While we focus on your clinical needs, our administrative team works in parallel to handle the logistics. We will verify your insurance benefits, manage the entire prior authorization process, and provide you with a clear financial plan outlining any copays or costs so there are no surprises. Before your first session, we’ll sit down with you for an education session to walk you through what to expect, discuss potential side effects, and answer all your questions. We’ll also help you plan the practical details, like arranging transportation home after each appointment, ensuring you feel confident, prepared, and fully supported as you take this important step toward recovery.
Frequently Asked Questions About Spravato Treatment
How effective is Spravato for treatment-resistant depression?
Spravato has demonstrated significant effectiveness for treatment-resistant depression in FDA approval studies. Clinical trials showed that 60-70% of patients with treatment-resistant depression experienced meaningful improvement when Spravato was added to their existing oral antidepressant. The medication works through a completely different mechanism than traditional antidepressants, targeting NMDA receptors rather than serotonin systems. This novel approach allows Spravato to be effective even when multiple previous antidepressants have failed. Response typically occurs within days rather than weeks, with many patients noticing initial improvements within 24-48 hours of treatment. Read our article on “What is the Best Treatment for Depression” to compare Spravato to other treatments like IV Ketamine, Deep TMS, and antidepressants.
What does Spravato treatment feel like?
During Spravato treatment, you’ll self-administer the nasal spray under medical supervision in our treatment facility. The medication may cause temporary side effects including mild dissociation (feeling detached or “floaty”), nausea, dizziness, or sedation. These effects typically peak 15-40 minutes after administration and gradually resolve over 2 hours. Many patients find the experience tolerable and even relaxing. You’ll remain conscious and able to communicate with staff throughout treatment. The 2-hour monitoring period allows any side effects to resolve before you go home. Transportation must be arranged as you cannot drive after treatment.
Does insurance cover Spravato treatment in Denver?
Many people wonder if ketamine therapy is covered by insurance. Most major insurance plans cover Spravato treatment for FDA-approved indications. We take insurance plans like Aetna, Anthem, Cigna, and United Healthcare and they typically cover treatment when medical criteria are met. Coverage requires documentation of treatment-resistant depression (failed trials of at least 2 antidepressants) and must be provided at REMS-certified facilities. Prior authorization is usually required but approval rates are high when criteria are met. Our insurance team handles all prior authorization paperwork and appeals to maximize your coverage. Unlike off-label ketamine treatment, Spravato’s FDA approval makes insurance coverage much more straightforward.
How often do I need Spravato treatments?
Spravato treatment follows an FDA-mandated schedule that starts with twice-weekly treatments for the first 4 weeks (induction phase), then weekly treatments for weeks 5-8 (optimization phase). After the initial 8 weeks, treatment frequency is individualized based on your response, ranging from weekly to monthly maintenance treatments. Most patients require ongoing treatment to maintain benefits, though the frequency often decreases over time as symptoms stabilize. The treatment schedule is designed to build and maintain the neuroplasticity changes that provide antidepressant benefits. Your psychiatric provider will work with you to find the optimal maintenance schedule.
Will I still be considered sober if I try ketamine therapy?
This is a common concern for people in recovery. Because some people abuse ketamine recreationally, they are afraid that a medical treatment delivered in a controlled, clinical setting is equivalent and may put sobriety at risk. We can’t generalize, but we can say that based on our experience treating thousands of patients, many of whom have had a substance abuse history in the past, sobriety is more than possible. But it depends on any individual’s recovery stability, how the treatment is structured, and whether it is clinically appropriate for you. These are all things we consider when our providers evaluate treatments for patients.
At Axis Integrated Mental Health, patient safety and long-term recovery come first. That’s why there is a clear requirement: patients must be sober for at least 6 months before starting ketamine-based treatments like Spravato. This helps ensure that:
- The treatment does not interfere with early recovery
- There is a stable baseline to accurately assess outcomes
- The risk of misuse or psychological destabilization is minimized
The goal is to treat conditions like depression, not to create an altered state for its own sake. Many patients in stable recovery are able to go through treatment without compromising their sobriety, especially when it is part of a structured, medically supervised plan.
That said, your concern is valid, and for some people, even the idea of using a dissociative medication can feel uncomfortable or triggering. If maintaining strict sobriety without any exposure to substances is important to you, Transcranial Magnetic Stimulation (TMS) may be a better fit. TMS:
The right answer depends on your history, your recovery goals, and your comfort level. A good provider will help you weigh options carefully, not push you into one path.The good news is that we offer both Deep TMS and Spravato at all of our facilities, so you can make the decision that’s right for you.
Transform Your Life with FDA-Approved Spravato Treatment
If you’ve struggled with treatment-resistant depression despite trying multiple antidepressants, Spravato offers genuine hope for rapid, meaningful improvement. This FDA-approved breakthrough treatment has helped thousands of people reclaim their lives when traditional medications failed to provide relief.
At Axis Integrated Mental Health, our Spravato specialists provide safe, expert care using FDA-mandated protocols in our REMS-certified facilities. We understand the frustration of failed treatments and are committed to helping you achieve the rapid relief you deserve through this innovative, well-researched therapy. Check out our new patient information center to learn what our patients have to say about getting Spravato treatments at Axis Integrated Mental Health and what you can do to prepare for treatment.
Don’t let treatment-resistant depression control your future. Spravato’s unique mechanism and rapid onset can provide the breakthrough you’ve been seeking, offering real hope for sustained recovery and improved quality of life within days, not months.
Ready to explore FDA-approved Spravato treatment? Breakthrough depression relief is available.
Schedule with a pscyhiatric provider online at axismh.com/book-online or call/text our Denver office at 720.400.7025 to speak with our benefits specialists about your treatment eligibility and insurance coverage for this life-changing therapy.